Lizunov AV, Okunevich IV, Orlov SV, Lebedev AA, Bychkov ER, Piotrovskiy LB, Shabanov PD. [Effects of сramizol on expression of the ApoA1 gene in rats with
experimental hyperlipidemia].
Biomed Khim 2019;
65:403-406. [PMID:
31666413 DOI:
10.18097/pbmc20196505403]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
An imidazole derivative cramizol, has lipid-lowering and anti-atherogenic effects. Cramizol reduces blood levels of cholesterol and triglycerides, and also reduces the atherogenic index in animals with acute hyperlipidemia induced by Triton WR-1339. Cramizol and the lipid-lowering drug fenofibrate exhibited similar effectiveness as hypolipidemic agents. Cramizol also restores the expression of the Apoa1 gene in rats with experimentally induced hyperlipidemia to normal values. This may be a basis of its hypolipidemic and anti-atherogenic action.
Collapse